Shopping Cart
- Remove All
Your shopping cart is currently empty
CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $40 | In Stock | |
| 10 mg | $64 | In Stock | |
| 25 mg | $129 | In Stock | |
| 50 mg | $213 | In Stock | |
| 100 mg | $318 | In Stock | |
| 500 mg | $759 | In Stock |
| Description | CXCL-CXCR1/2-IN-1 is an orally active and potent inhibitor of the ELR+CXCL-CXCR1/2 pathway with anticancer and anti-angiogenic activity and can be used to study cardiovascular disease and cancer. |
| In vitro | CXCL-CXCR1/2-IN-1 (compound 10; 1-2.5 μM; 24-48h; A498 cells) showed reduced ERK and AKT phosphorylation in A498 cells. CXCL-CXCR1/2-IN-1 also can inhibit the secretion of CXCL1, CXCL5, and CXCL8, which are representative pro-angiogenic ELR+CXCL cytokines.[1] |
| In vivo | CXCL-CXCR1/2-IN-1 (1 μM; 48h; Female NOD SCID mice injected with 786 RCC cells) reduces the metastatic area in zebrafish embryos injected with A498 cells.[1] CXCL-CXCR1/2-IN-1 (100 mg/kg; oral gavage; twice a day; for 28 days) inhibits tumor growth in mice.[1] |
| Molecular Weight | 383.21 |
| Formula | C14H8Cl2N4O3S |
| Cas No. | 2415653-55-1 |
| Smiles | O=C(NC1=CC(Cl)=CC(Cl)=C1)NC2=NC3=C(S2)C=C([N+]([O-])=O)C=C3 |
| Relative Density. | 1.722 g/cm3 at 20℃ (Predicted) |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | DMSO: 2 mg/mL (5.22 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
| ||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.